reports
- Wedbush Research
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PANW PALO ALTO NETWORKS INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MXL MAXLINEAR INC
MU MICRON TECHNOLOGY INC.
MTH MERITAGE HOMES CORPORATION
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
DKS DICK'S SPORTING GOODS INC.
AXTI AXT INC.
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
VFC V.F. CORPORATION
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
AVGO BROADCOM INC.
SMCI SUPER MICRO COMPUTER
MRVL INC.
STX MARVELL TECHNOLOGY INC
GFS SEAGATE TECHNOLOGY HLDGS PLC
GLOBALFOUNDRIES INC
- Matthew McCartney
- Nathan Friedman
- Seth Basham
- Jonathan Moreland
CLOV CLOVER PAKISTAN LTD.
INVE INDENTIV
EAF GRAFTECH INTERNATIONAL
ALLO ALLOGENE THERAPEUTICS
REKR REKOR SYSTEMS
PHGE BIOMX INC
TMCI TREACE MED CONCEPTS INC
TCBX THIRD COAST BANCSHARES INC
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
ABEO ABEONA THERAPEUTICS INC.
MDRR MEDALIST DIVERSIFIED REIT INC.
VSTS_w VESTIS CORPORATION
BHRB BURKE HERBERT FINANCIAL SERVICES CORP
German American Bank Earns Top Community Bank Recognitions from Forbes...
German American Bank Earns Top Community Bank Recognitions from Forbes and Raymond James JASPER, Ind., May 20, 2024 (GLOBE NEWSWIRE) -- German American Bank was named to the Forbes America’s Best Banks list, ranking 19th among 200 eligible banks. In addition, German American Bank earned accolades as a top community bank with a #15 ranking in the Raymond James Community Bankers Cup awards. “As a community bank, we understand the importance of maintaining a position of strength and stability,” states D. Neil Dauby, Chairman and CEO of German American Bank. “We are thrilled to receive t...
Heartland Express, Inc. Announces Participation in Upcoming Conference
Heartland Express, Inc. Announces Participation in Upcoming Conference NORTH LIBERTY, Iowa, May 20, 2024 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) announced that Chris Strain, Chief Financial Officer, and Josh Helmich, Senior Vice President and Chief Financial Officer of CFI (a wholly owned subsidiary) will participate in the Wolfe Research 17th Annual Global Transportation and Industrials Conference. Conference participation will occur on Wednesday, May 22, 2024, in New York, New York, including investor meetings. Heartland Express is an irregular route truckload carrie...
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
TWI TITAN INTERNATIONAL INC.
TNET TRINET GROUP INC.
RYI RYERSON HOLDING CORPORATION
PZZA PAPA JOHN'S INTERNATIONAL INC.
PII POLARIS INC.
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
JACK JACK IN THE BOX INC.
HURN HURON CONSULTING GROUP INC.
FIVE FIVE BELOW INC.
EXTR EXTREME NETWORKS INC.
EXPE EXPEDIA GROUP INC.
EXEL EXELIXIS INC.
EXAS EXACT SCIENCES CORPORATION
EVH EVOLENT HEALTH INC CLASS A
CLX CLOROX COMPANY
ACAD ACADIA PHARMACEUTICALS INC.
BF.B BROWN-FORMAN CORPORATION CLASS B
COHU COHU INC.
IONS IONIS PHARMACEUTICALS INC.
LEG LEGGETT & PLATT INCORPORATED
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
THS TREEHOUSE FOODS INC.
WH WYNDHAM HOTELS & RESORTS INC.
BMY BRISTOL-MYERS SQUIBB CO. CEDEAR
SUZBY SUZANO SA
PGNY PROGYNY
ODP THE ODP CORPORATION
APA APA CORPORATION
PTLO PORTILLOS INC
STVN STEVANATO GRP SPA
FNA PARAGON 28 INC
SHLS SAKHALIN SHIPPING CO ORD
P RAILPOWER TECHNOLOGIES CORP COM
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth...
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Boston, May 16, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO and President, Roy Schoenberg, M.D., M.P.H., will speak at the at 12:15 PST on Saturday, May 18. The virtual conference explores barriers to telehealth enhancement for those with disabilities and the innovative solutions underway to advance hea...
Douglas Dynamics Announces CEO Transition
Douglas Dynamics Announces CEO Transition President & CEO Bob McCormick Retiring from the Company in July; Current Chairman Jim Janik will Assume Interim President & CEO role MILWAUKEE, May 16, 2024 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced the start of a CEO transition process. Robert McCormick (Bob) has informed the Board of Directors of his intention to retire from the company and the Board of Directors in July 2024, after 20 years of service. Upon his retireme...
Axogen Inc. Initiates Rolling Submission of Biologics License Applicat...
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft® ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft® on May 15, 2024. “Today’s milestone represents a signific...
Treehouse Foods Inc: 1 director
A director at Treehouse Foods Inc sold 3,723 shares at 34.990USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads C...
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference ALACHUA, Fla. and TAMPA, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, chief executive officer, and president, will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference in Austin, TX, on Wednesday, May 29, 2024, at 3:40 p.m. CT / 4:40 p.m. ET. Webcast events can be accessed live through the page at . For...
Barnwell Industries, Inc. Reports Results for its Second Quarter Ended...
Barnwell Industries, Inc. Reports Results for its Second Quarter Ended March 31, 2024 Production Increases for All Products Continued Reduction in General and Administrative Expenses HONOLULU, May 14, 2024 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) today reported financial results for its second fiscal quarter ended March 31, 2024. For the quarter, the Company had revenue of $5,774,000 and a net loss of $1,772,000, $0.18 per share. In the three months ended March 31, 2023, the Company reported quarterly revenue of $5,239,000 and a net loss of $1,237,000, $0.12 pe...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SAIA SAIA INC.
RYI RYERSON HOLDING CORPORATION
RM REGIONAL MANAGEMENT CORP
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
LTRX LANTRONIX INC.
KMPR KEMPER CORPORATION
HUBB HUBBELL INCORPORATED CLASS B
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
AIN ALBANY INTERNATIONAL CORP. CLASS A
HWBK HAWTHORN BANCSHARES
EFR ENERGY FUELS
SABR SABRE CORP.
ALPN ALPINE SELECT AG
HTLD HEARTLAND EXPRESS INC.
MAC MACERICH COMPANY
HI HILLENBRAND INC.
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
CRVS CORVUS PHARMACEUTICALS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
EAF GRAFTECH INTERNATIONAL
FRAF FRANKLIN FINANCIAL SERVICES CO.
BBDC BARINGS BDC INC.
GH GUARDANT HEALTH
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
CZR CAESARS ENTERTAINMENT INC
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
MEGI THE BANCORP
NPCT INC.
RXO_w MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w RXO INC
NBBK BEYON 3D LTD
ASGI VESTIS CORPORATION
EYPT NB BANCORP INC.
DBD ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYEPOINT PHARMACEUTICALS
INC.
DIEBOLD NIXDORF INCORPORATED
iTeos meldet Finanzergebnisse für das erste Quartal 2024 und gibt aktu...
iTeos meldet Finanzergebnisse für das erste Quartal 2024 und gibt aktuelle Geschäftsinformationen bekannt - Belrestotug + Dostarlimab übertraf die vordefinierten Wirksamkeitskriterien für klinisch relevante Aktivität, die in einer Zwischenbewertung der Phase 2 von GALAXIES Lung-201 beobachtet wurde - Klinisch bedeutsame Tumorreduktion wurde bei jeder Belrestotug + Dostarlimab-Dosis im Vergleich zur Monotherapie beobachtet - GSK wird bei der kommenden Investorenveranstaltung im Juni ein Update zum GALAXIES-Programm geben - RA Capital und Boxer Capital führen registrierte Direktemission in...
iTeos fait le point sur ses activités et publie ses résultats financie...
iTeos fait le point sur ses activités et publie ses résultats financiers pour le premier trimestre 2024 - Le doublet belrestotug + dostarlimab a dépassé les critères d’efficacité prédéfinis pour une activité cliniquement pertinente constatée lors d’une évaluation intérimaire de Phase 2 sur GALAXIES Lung-201 - Une réduction tumorale cliniquement significative a été observée à chaque administration de dose de belrestotug + dostarlimab par rapport à la monothérapie - GSK fournira une mise à jour du programme d’étude GALAXIES lors du prochain événement organisé à l’attention des investisseurs...
iTeos Therapeutics gibt registrierte Direktplatzierung im Wert von 120...
iTeos Therapeutics gibt registrierte Direktplatzierung im Wert von 120 Mio. USD bekannt -Angeführt von den bestehenden Investoren RA Capital Management und Boxer Capital- Kaufpreis von 17,50 USD entspricht einem Aufschlag von ca. 44 % auf den letzten Schlusskurs- Weitere Stärkung der Bilanz mit einem Pro-forma-Barmittelbestand von 715 Mio. USD, der die erwartete Laufzeit bis 2027 verlängert WATERTOWN, Massachusetts, und GOSSELIES, Belgien, May 11, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) („iTeos“), ein im klinischen Stadium tätiges Biopharmazieunternehmen, das Pio...
iTeos Therapeutics annonce une offre directe enregistrée de 120 millio...
iTeos Therapeutics annonce une offre directe enregistrée de 120 millions de dollars - Pilotage assuré par les investisseurs actuels RA Capital Management et Boxer Capital- Prix d’achat fixé à 17,50 dollars, soit une prime d’environ 44 % par rapport à la dernière clôture- Renforcement du bilan avec une trésorerie pro forma de 715 millions de dollars, prolongeant la marge de manœuvre prévue jusqu’en 2027 WATERTOWN, État du Massachusetts et GOSSELIES, Belgique, 11 mai 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq : ITOS) (« iTeos »), une société biopharmaceutique au stade cliniq...
iTeos Reports First Quarter 2024 Financial Results and Provides Busine...
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates - Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 GALAXIES Lung-201- Clinically meaningful tumor reduction observed at every belrestotug + dostarlimab dose vs monotherapy- GSK to provide update on GALAXIES program at upcoming investor event in June- RA Capital and Boxer Capital led $120 million registered direct offering at $17.50, representing a premium of approximately 44% to last close- Pro forma cash and investmen...
iTeos Therapeutics Announces $120 Million Registered Direct Offering
iTeos Therapeutics Announces $120 Million Registered Direct Offering - Led by existing investors RA Capital Management and Boxer Capital- Purchase price of $17.50 represents a premium of approximately 44% to last close- Further strengthens balance sheet with pro forma cash position of $715 million, extending anticipated runway through 2027 WATERTOWN, Mass. and GOSSELIES, Belgium, May 10, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology ther...
- David Carlson
- David Nierengarten
- Dennis Pak
- Martin Fan
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.